Interactive Financial Charts Not Available

Clorox Company (CLX) | Financial Analysis & Statements

The Clorox Company | Large-cap | Consumer Defensive

$120.31

0.39%

Clorox Company vs Procter & Gamble Clorox Company vs Colgate-Palmolive Clorox Company vs Kimberly-Clark Clorox Company vs Kenvue Clorox Company vs Estee Lauder Clorox Company vs S&P 500 | Market

TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 2.0B

Gross Profit 924.0M 46.48%

Operating Income 420.0M 21.13%

Net Income 336.0M 16.90%

Balance Sheet Metrics

Total Assets 5.6B

Total Liabilities 5.1B

Shareholders Equity 482.0M

Debt to Equity 10.54

Cash Flow Metrics

Operating Cash Flow 312.0M

Free Cash Flow 219.0M

Revenue & Profitability Trend

Interactive Financial Charts Not Available

This page uses interactive financial charts and dynamic data visualization tools that require JavaScript. For detailed financial analysis:

Available Financial Data:

Income statements (annual and quarterly)
Balance sheets with asset and liability details
Cash flow statements and free cash flow analysis
Key financial ratios and performance metrics
Peer comparison and industry benchmarking

All financial data is displayed in accessible table format below. Use the table headers and structure to analyze trends and compare metrics across different periods.

Clorox Company Income Statement From 2021 to 2025

Metric	2025	2024	2023	2022	2021
Revenue i	7.1B	7.1B	7.4B	7.1B	7.3B
Cost of Goods Sold i	3.9B	4.0B	4.5B	4.6B	4.1B
Gross Profit i	3.2B	3.0B	2.9B	2.5B	3.2B
Gross Margin % i	45.2%	43.0%	39.4%	35.8%	43.6%
Operating Expenses
Research & Development i	121.0M	126.0M	138.0M	132.0M	149.0M
Selling, General & Administrative i	1.9B	2.2B	1.9B	1.7B	1.8B
Other Operating Expenses i	-	-	-	-14.0M	-
Total Operating Expenses i	2.0B	2.3B	2.1B	1.8B	1.9B
Operating Income i	1.2B	723.0M	823.0M	719.0M	1.2B
Operating Margin % i	16.6%	10.2%	11.1%	10.1%	16.7%
Non-Operating Items
Interest Income i	9.0M	23.0M	16.0M	5.0M	5.0M
Interest Expense i	88.0M	90.0M	90.0M	106.0M	99.0M
Other Non-Operating Income	-20.0M	-258.0M	-511.0M	-11.0M	-231.0M
Pre-tax Income i	1.1B	398.0M	238.0M	607.0M	900.0M
Income Tax i	254.0M	106.0M	77.0M	136.0M	181.0M
Effective Tax Rate % i	23.6%	26.6%	32.4%	22.4%	20.1%
Net Income i	824.0M	292.0M	161.0M	471.0M	719.0M
Net Margin % i	11.6%	4.1%	2.2%	6.6%	9.8%
Key Metrics
EBITDA i	1.4B	968.0M	1.1B	947.0M	1.4B
EPS (Basic) i	-	$2.26	$1.21	$3.75	$5.66
EPS (Diluted) i	-	$2.25	$1.20	$3.73	$5.58
Basic Shares Outstanding i	-	124174000	123589000	123113000	125570000
Diluted Shares Outstanding i	-	124174000	123589000	123113000	125570000

Income Statement Trend

Clorox Company Balance Sheet From 2021 to 2025

Metric	2025	2024	2023	2022	2021
Assets
Current Assets
Cash & Equivalents i	167.0M	202.0M	367.0M	183.0M	319.0M
Short-term Investments i	-	-	-	-	-
Accounts Receivable i	805.0M	695.0M	688.0M	681.0M	604.0M
Inventory i	523.0M	637.0M	696.0M	755.0M	752.0M
Other Current Assets	97.0M	88.0M	77.0M	106.0M	154.0M
Total Current Assets i	1.6B	1.6B	1.8B	1.7B	1.8B
Non-Current Assets
Property, Plant & Equipment i	333.0M	360.0M	346.0M	342.0M	332.0M
Goodwill i	3.0B	3.1B	3.2B	4.0B	4.1B
Intangible Assets i	566.0M	681.0M	712.0M	884.0M	918.0M
Long-term Investments	-	-	-	-	-
Other Non-Current Assets	558.0M	545.0M	462.0M	315.0M	378.0M
Total Non-Current Assets i	4.0B	4.1B	4.1B	4.4B	4.5B
Total Assets i	5.6B	5.8B	5.9B	6.2B	6.3B
Liabilities
Current Liabilities
Accounts Payable i	838.0M	950.0M	1.0B	960.0M	930.0M
Short-term Debt i	91.0M	88.0M	137.0M	315.0M	381.0M
Current Portion of Long-term Debt	-	-	-	-	-
Other Current Liabilities	-	-	-	-	-
Total Current Liabilities i	1.9B	1.6B	1.9B	1.8B	2.1B
Non-Current Liabilities
Long-term Debt i	2.8B	2.8B	2.8B	2.8B	2.8B
Deferred Tax Liabilities i	20.0M	22.0M	28.0M	66.0M	67.0M
Other Non-Current Liabilities	28.0M	536.0M	523.0M	486.0M	457.0M
Total Non-Current Liabilities i	3.2B	3.7B	3.6B	3.6B	3.7B
Total Liabilities i	5.1B	5.3B	5.6B	5.4B	5.7B
Equity
Common Stock i	131.0M	131.0M	131.0M	131.0M	131.0M
Retained Earnings i	432.0M	250.0M	583.0M	1.0B	1.0B
Treasury Stock i	1.4B	1.2B	1.2B	1.3B	1.4B
Other Equity	-	-	-	-	-
Total Shareholders Equity i	482.0M	492.0M	388.0M	729.0M	592.0M
Key Metrics
Total Debt i	2.9B	2.9B	2.9B	3.1B	3.2B
Working Capital i	-311.0M	48.0M	-89.0M	-59.0M	-227.0M

Balance Sheet Composition

Clorox Company Cash Flow Statement From 2021 to 2025

Metric	2025	2024	2023	2022	2021
Operating Activities
Net Income i	824.0M	292.0M	161.0M	471.0M	719.0M
Depreciation & Amortization i	219.0M	235.0M	236.0M	224.0M	211.0M
Stock-Based Compensation i	81.0M	74.0M	73.0M	52.0M	50.0M
Working Capital Changes i	-202.0M	-266.0M	355.0M	-115.0M	19.0M
Operating Cash Flow i	878.0M	261.0M	714.0M	656.0M	977.0M
Investing Activities
Capital Expenditures i	-	-	-	-	-
Acquisitions i	128.0M	17.0M	0	0	-85.0M
Investment Purchases i	-	-	-	-	-
Investment Sales i	-	-	-	-	-
Investing Cash Flow i	126.0M	37.0M	5.0M	22.0M	-121.0M
Financing Activities
Share Repurchases i	-332.0M	0	0	-25.0M	-905.0M
Dividends Paid i	-602.0M	-595.0M	-583.0M	-571.0M	-558.0M
Debt Issuance i	-	0	0	1.1B	0
Debt Repayment i	-	0	0	-1.4B	0
Financing Cash Flow i	-950.0M	-656.0M	-786.0M	-694.0M	-1.5B
Free Cash Flow i	761.0M	483.0M	930.0M	535.0M	945.0M
Net Change in Cash i	54.0M	-358.0M	-67.0M	-16.0M	-638.0M

Cash Flow Trend

Clorox Company Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 18.47

Forward P/E 16.52

Price to Book 46.04

Price to Sales 2.07

PEG Ratio 16.52

Profitability Ratios

Profit Margin 11.40%

Operating Margin 20.98%

Return on Equity 169.20%

Return on Assets 13.10%

Financial Health

Current Ratio 0.84

Debt to Equity 604.98

Beta 0.49

Per Share Data

EPS (TTM) $6.52

Book Value per Share $2.62

Revenue per Share $57.51

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
clx	14.7B	18.47	46.04	169.20%	11.40%	604.98
Procter & Gamble	371.0B	24.33	7.24	31.24%	18.95%	69.86
Colgate-Palmolive	68.8B	23.90	97.89	398.04%	14.54%	832.51
Kimberly-Clark	47.7B	19.60	43.35	207.06%	12.48%	595.10
Kenvue	40.5B	28.13	3.77	13.56%	9.37%	81.49
Estee Lauder	31.6B	124.05	7.26	-15.98%	-5.89%	215.93

Financial data is updated regularly. All figures are in the company's reporting currency.